Yarchoan, M., Powderly, J. D., Bastos, B. R., Karasic, T. B., Crysler, O. V., Munster, P. N., McKean, M. A., Emens, L. A., Saenger, Y. M., Ged, Y., Stagg, R., Smith, S., Whiting, C. C., Moon, A., Prasit, P., Jenkins, Y., Standifer, N., Dubensky, T. W., Whiting, S. H., & Ulahannan, S. V. (2024). First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors. Cancer Research Communications, 4(4), 1100–1110. https://doi.org/10.1158/2767-9764.crc-24-0082

Ross, A. B., Gorhe, D., Kim, J. K., Hodapp, S., DeVine, L., Chan, K. M., Chio, I. I. C., Jovanovic, M., & Ayres Pereira, M. (2024). Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO. Cell Reports Methods, 4(5), 100760. https://doi.org/10.1016/j.crmeth.2024.100760

Tzaridis, T., & Wechsler-Reya, R. J. (2024). Just a spoonful of metformin helps the medicine go down. Journal of Clinical Investigation, 134(6). https://doi.org/10.1172/jci179144

Nguyen, T. T. T., Torrini, C., Shang, E., Shu, C., Mun, J.-Y., Gao, Q., Humala, N., Akman, H. O., Zhang, G., Westhoff, M.-A., Karpel-Massler, G., Bruce, J. N., Canoll, P., & Siegelin, M. D. (2024). OGDH and Bcl-xL loss causes synthetic lethality in glioblastoma. JCI Insight. https://doi.org/10.1172/jci.insight.172565

Lee, I. Y., Hanft, S., Schulder, M., Judy, K. D., Wong, E. T., Elder, J. B., Evans, L. T., Zuccarello, M., Wu, J., Aulakh, S., Agarwal, V., Ramakrishna, R., Gill, B. J., Quiñones-Hinojosa, A., Brennan, C., Zacharia, B. E., Silva Correia, C. E., Diwanji, M., Pennock, G. K., … Boockvar, J. A. (2024). Autologous Cell Immunotherapy (IGV-001) with IGF-1R Antisense Oligonucleotide in Newly Diagnosed Glioblastoma Patients. Future Oncology, 20(10), 579–591. https://doi.org/10.2217/fon-2023-0702

Chen, F., Tang, C., Yang, F., Ekpenyong, A., Qin, R., Xie, J., Momen-Heravi, F., Saba, N. F., & Teng, Y. (2024). HSP90 inhibition suppresses tumor glycolytic flux to potentiate the therapeutic efficacy of radiotherapy for head and neck cancer. Science Advances, 10(8). https://doi.org/10.1126/sciadv.adk3663

Ali, S. R., Nguyen, N. U. N., Menendez-Montes, I., Hsu, C.-C., Elhelaly, W., Lam, N. T., Li, S., Elnwasany, A., Nakada, Y., Thet, S., Foo, R. S. Y., & Sadek, H. A. (2024). Hypoxia-induced stabilization of HIF2A promotes cardiomyocyte proliferation by attenuating DNA damage. The Journal of Cardiovascular Aging, 4(1). https://doi.org/10.20517/jca.2023.43

Picca, A., Di Stefano, A. L., Savatovsky, J., Ducray, F., Chinot, O., Moyal, E. C.-J., Augereau, P., Le Rhun, E., Schmitt, Y., Rousseaux, N., Yepnang, A. M. M., Estellat, C., Charbonneau, F., Letourneur, Q., Branger, D. F., Meyronet, D., Fardeau, C., Mokhtari, K., Bielle, F., … Sanson, M. (2024). TARGET: A phase I/II open-label multicenter study to assess safety and efficacy of fexagratinib in patients with relapsed/refractory FGFR fusion-positive glioma. Neuro-Oncology Advances, 6(1). https://doi.org/10.1093/noajnl/vdae068

Li, A. M., He, B., Karagiannis, D., Li, Y., Jiang, H., Srinivasan, P., Ramirez, Y., Zhou, M.-N., Curtis, C., Gruber, J. J., Lu, C., Rankin, E. B., & Ye, J. (2023). Serine starvation silences estrogen receptor signaling through histone hypoacetylation. Proceedings of the National Academy of Sciences, 120(38). https://doi.org/10.1073/pnas.2302489120

Fernandez Garcia, E., Paudel, U., Noji, M. C., Bowman, C. E., Rustgi, A. K., Pitarresi, J. R., Wellen, K. E., Arany, Z., Weissenrieder, J. S., & Foskett, J. K. (2023). The mitochondrial Ca2+ channel MCU is critical for tumor growth by supporting cell cycle progression and proliferation. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1082213

Boboila, S., Okochi, S., Banerjee, D., Barton, S., Street, C., Zenilman, A. L., Wang, Q., Gartrell, R. D., Saenger, Y. M., Welch, D., Wu, C.-C., Kadenhe-Chiweshe, A., Yamashiro, D. J., & Connolly, E. P. (2023). Combining immunotherapy with high-dose radiation therapy (HDRT) significantly inhibits tumor growth in a syngeneic mouse model of high-risk neuroblastoma. Heliyon, 9(6), e17399. https://doi.org/10.1016/j.heliyon.2023.e17399

Shang, E., Nguyen, T. T. T., Westhoff, M.-A., Karpel-Massler, G., & Siegelin, M. D. (2023). Targeting cellular respiration as a therapeutic strategy in glioblastoma. Oncotarget, 14(1), 419–425. https://doi.org/10.18632/oncotarget.28424

Lemmetyinen, T. T., Viitala, E. W., Wartiovaara, L., Kaprio, T., Hagström, J., Haglund, C., Katajisto, P., Wang, T. C., Domènech-Moreno, E., & Ollila, S. (2023). Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth. Disease Models & Mechanisms, 16(4). https://doi.org/10.1242/dmm.049692

Garcia, J. A., Chen, R., Xu, M., Comerford, S. A., Hammer, R. E., Melton, S. D., & Feagins, L. A. (2023). Acss2/HIF-2 signaling facilitates colon cancer growth and metastasis. PLOS ONE, 18(3), e0282223. https://doi.org/10.1371/journal.pone.0282223

Tasic, L., Avramović, N., Jadranin, M., Quintero, M., Stanisic, D., Martins, L. G., Costa, T. B. B. C., Novak, E., Odone, V., Rivas, M., Aguiar, T., Carraro, D. M., Werneck da Cunha, I., Lima da Costa, C. M., Maschietto, M., & Krepischi, A. (2022). High-Resolution Magic-Angle-Spinning NMR in Revealing Hepatoblastoma Hallmarks. Biomedicines, 10(12), 3091. https://doi.org/10.3390/biomedicines10123091

Filippone, M. G., Gaglio, D., Bonfanti, R., Tucci, F. A., Ceccacci, E., Pennisi, R., Bonanomi, M., Jodice, G., Tillhon, M., Montani, F., Bertalot, G., Freddi, S., Vecchi, M., Taglialatela, A., Romanenghi, M., Romeo, F., Bianco, N., Munzone, E., Sanguedolce, F., … Pece, S. (2022). CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30375-8

Schvartzman, J. M., & Intlekofer, A. M. (2022). D-2HG comes out of its shell: Metabolic effects on the immune environment. Molecular Cell, 82(23), 4407–4409. https://doi.org/10.1016/j.molcel.2022.11.005

Baran, N., Lodi, A., Dhungana, Y., Herbrich, S., Collins, M., Sweeney, S., Pandey, R., Skwarska, A., Patel, S., Tremblay, M., Kuruvilla, V. M., Cavazos, A., Kaplan, M., Warmoes, M. O., Veiga, D. T., Furudate, K., Rojas-Sutterin, S., Haman, A., Gareau, Y., … Konopleva, M. (2022). Inhibition of mitochondrial complex I reverses NOTCH1-driven metabolic reprogramming in T-cell acute lymphoblastic leukemia. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-30396-3

Pan, P., Haggiagi, A., & Iwamoto, F. (2022). BIOM-12. PROLONGED RESPONSE TO THIRD-LINE TREATMENT WITH COMBINATION CCNU/TMZ IN AN MGMT METHYLATED IDH-WILDTYPE GLIOBLASTOMA. Neuro-Oncology, 24(Supplement_7), vii6–vii6. https://doi.org/10.1093/neuonc/noac209.022

Iwamoto, F., Polley, M.-Y., Shaw, E., Buckner, J., Barger, G., Coons, S., Ricci, P., Gilbert, M., Brown, P., Stelzer, K., Rogers, C. L., Suh, J., Schultz, C., Howard, S., Fisher, B., Kim, M., Huang, J., Haddock, M., Won, M., & Mehta, M. (2022). CTNI-16. NRG-RTOG 9802 OBSERVATION ARM - LONG TERM RESULT. Neuro-Oncology, 24(Supplement_7), vii73–vii73. https://doi.org/10.1093/neuonc/noac209.282

Arrillaga-Romany, I., Lassman, A., McGovern, S., Mueller, S., Nabors, L. B., van den Bent, M., Vogelbaum, M., Allen, J. E., Melemed, A., Tarapore, R., Yang, D., Wen, P. Y., & Cloughesy, T. (2022). RTID-01. ONC108: A RANDOMIZED PHASE 3 STUDY OF ONC201 IN PATIENTS WITH NEWLY DIAGNOSED H3 K27M-MUTANT DIFFUSE GLIOMA. Neuro-Oncology, 24(Supplement_7), vii249–vii249. https://doi.org/10.1093/neuonc/noac209.961

Oh, M., Hasanain, M., Migliozzi, S., Garofano, L., D’Angelo, F., Stefano, A. L. D., Lerond, J., Sarkaria, J., Ceccarelli, M., Sanson, M., Lasorella, A., & Iavarone, A. (2022). EXTH-21. DEVELOPMENT OF THERAPEUTIC STRATEGIES BY PATHWAY-BASED MULTI-OMICS APPROACH AND MASTER KINASE ANALYSIS IN GLIOBLASTOMA MULTIFORME. Neuro-Oncology, 24(Supplement_7), vii214–vii214. https://doi.org/10.1093/neuonc/noac209.820

He, D., Feng, H., Sundberg, B., Yang, J., Powers, J., Christian, A. H., Wilkinson, J. E., Monnin, C., Avizonis, D., Thomas, C. J., Friedman, R. A., Kluger, M. D., Hollingsworth, M. A., Grandgenett, P. M., Klute, K. A., Toste, F. D., Chang, C. J., & Chio, I. I. C. (2022). Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. Molecular Cell, 82(16), 3045-3060.e11. https://doi.org/10.1016/j.molcel.2022.06.005

Arrillaga-Romany, I., Kurz, S., Tarapore, R., Lu, G., Sumrall, A., Butowski, N., Harrison, R., DeGroot, J., Chi, A., Shonka, N., Umemura, Y., Odia, Y., Mehta, M., Nghiemphu, P., Cloughesy, T., Taylor, L., Graber, J., Kilburn, L., Dixit, K., … Wen, P. (2022). SYST-14 CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA (DMG) PATIENTS. Neuro-Oncology Advances, 4(Supplement_1), i24–i24. https://doi.org/10.1093/noajnl/vdac078.093

Torrini, C., Nguyen, T. T. T., Shu, C., Mela, A., Humala, N., Mahajan, A., Seeley, E. H., Zhang, G., Westhoff, M.-A., Karpel-Massler, G., Bruce, J. N., Canoll, P., & Siegelin, M. D. (2022). Lactate is an epigenetic metabolite that drives survival in model systems of glioblastoma. Molecular Cell, 82(16), 3061-3076.e6. https://doi.org/10.1016/j.molcel.2022.06.030

Trudeau, T., Prince, E., Chatain, O., Chee, K., Jackson, E., Limbrick, D., Naftel, R., Feldstein, N., Grant, G., Ginn, K., Niazi, T., Smith, A., Kilburn, L., Chern, J., Drapeau, A., Lam, S., Johnston, J., Dudley, R., Staulcup, S., & Hankinson, T. (2022). RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response. Neuro-Oncology, 24(Supplement_1), i15–i15. https://doi.org/10.1093/neuonc/noac079.049

Nguyen, T. T. T., Shang, E., Schiffgens, S., Torrini, C., Shu, C., Akman, H. O., Prabhu, V. V., Allen, J. E., Westhoff, M.-A., Karpel-Massler, G., & Siegelin, M. D. (2022). Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma. Clinical Cancer Research, 28(9), 1881–1895. https://doi.org/10.1158/1078-0432.ccr-21-2857

Lu, H., Gomaa, A., Wang-Bishop, L., Ballout, F., Hu, T., McDonald, O., Washington, M. K., Livingstone, A. S., Wang, T. C., Peng, D., El-Rifai, W., & Chen, Z. (2022). Unfolded Protein Response Is Activated by Aurora Kinase A in Esophageal Adenocarcinoma. Cancers, 14(6), 1401. https://doi.org/10.3390/cancers14061401

Lomas-Francis, C., Stone, E. F., Westhoff, C. M., & Shi, P. A. (2022). Intricacies of GATA-ca, continued. Haematologica, 107(8), 1988. https://doi.org/10.3324/haematol.2022.280876